GENEDX HOLDINGS CORP (WGS)

US81663L2007 - Common Stock

32.8  -1.42 (-4.15%)

After market: 32.8 0 (0%)

Full profile views are only available for registered users, you can see which data is available below.

Examples of complete profiles are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional data.

GENEDX HOLDINGS CORP

NASDAQ:WGS (7/12/2024, 3:16:57 PM)

After market: 32.8 0 (0%)

32.8

-1.42 (-4.15%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Providers & Services
GICS SubIndustry
Chartmill FA Rating
Valuation
Growth
Profitability
Health
Dividend
Chartmill High Growth Momentum
EPS Q2Q%
Sales Q2Q%
CRS
6 Month834.97%
Overview
Earnings (Last)
Earnings (Next)
Ins Owners
Inst Owners
Market Cap857.72M
Shares
PEN/A
Fwd PEN/A
Dividend YieldN/A
Analysts
IPO
Stock Screener Links
Screen Image

Nasdaq Stock Screener

Find more stocks on Nasdaq

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

GICS Sector Stock Screener

Find competitors from the same sector on the USA

Screen Image

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Screen Image

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

WGS Daily chart

Company Profile

GeneDx Holdings Corp. is a patient centered health intelligence company. The company is headquartered in Stamford, Connecticut and currently employs 1,100 full-time employees. The company went IPO on 2020-09-04. The firm is focused on delivering personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The Company’s segments are GeneDx and Legacy Sema4. The GeneDx segment primarily provides pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing and, to a lesser extent, data and information services. GeneDx utilizes an integrated portfolio of laboratory processes, software tools, and informatics capabilities to process deoxyribonucleic acid (DNA)-containing samples, analyze information about patient-specific genetic variation and generate test reports for clinicians and their patients. GeneDx provides a variety of genetic diagnostic tests, screening solutions, and information. The Legacy Sema4 diagnostics segment provides reproductive and women’s health and somatic oncology diagnostic testing and screening products.

Company Info

GENEDX HOLDINGS CORP

333 Ludlow Street, North Tower, 8Th Floor

Stamford CONNECTICUT

P: 16177808742

Employees: 1100

Website: https://sema4.com/

WGS News

News Imagea day ago - GeneDx Holdings Corp.GeneDx to Report Second Quarter 2024 Financial Results on Tuesday, July 30, 2024
News Imagea day ago - GeneDx Holdings Corp.GeneDx to Report Second Quarter 2024 Financial Results on Tuesday, July 30, 2024

GeneDx (Nasdaq: WGS) today announced it will release financial results for the second quarter of 2024 after the market closes on Tuesday, July 30, 2024....

News Image6 days ago - InvestorPlace7 Small-Cap Stocks With Massive Potential Returns

Explore these small-cap stocks with high potential in health care, REITs, entertainment, hardware, finance, and distribution industries.

News Imagea month ago - GeneDx Holdings Corp.GeneDx Announces Collaboration with Epic Aura to Expand Access to Rapid Whole Genome Sequencing (rWGS) Services to Inform Diagnosis in Affected Pediatric and Neonatal Patients
News Imagea month ago - GeneDx Holdings Corp.GeneDx Announces Collaboration with Epic Aura to Expand Access to Rapid Whole Genome Sequencing (rWGS) Services to Inform Diagnosis in Affected Pediatric and Neonatal Patients

-- New integration to streamline access for health systems and improve provider and patient journeys using Epic for electronic connections -- -- Increases...

News Imagea month ago - GeneDx Holdings Corp.GeneDx Announces Patient Access Program to Expand Access to Exome Testing for Pediatric Epilepsy Patients

WGS Twits

Here you can normally see the latest stock twits on WGS, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example